FI935780A - HIV-proteasinhibitorer, vilka aer anvaendbara vid behandling av AIDS - Google Patents
HIV-proteasinhibitorer, vilka aer anvaendbara vid behandling av AIDS Download PDFInfo
- Publication number
- FI935780A FI935780A FI935780A FI935780A FI935780A FI 935780 A FI935780 A FI 935780A FI 935780 A FI935780 A FI 935780A FI 935780 A FI935780 A FI 935780A FI 935780 A FI935780 A FI 935780A
- Authority
- FI
- Finland
- Prior art keywords
- aids
- treatment
- protease inhibitors
- hiv protease
- inhibitors useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99562192A | 1992-12-22 | 1992-12-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI935780A0 FI935780A0 (fi) | 1993-12-21 |
| FI935780A true FI935780A (sv) | 1994-06-23 |
Family
ID=25542022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI935780A FI935780A (sv) | 1992-12-22 | 1993-12-21 | HIV-proteasinhibitorer, vilka aer anvaendbara vid behandling av AIDS |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0609625A1 (sv) |
| JP (1) | JPH06256277A (sv) |
| KR (1) | KR940014336A (sv) |
| CN (1) | CN1092410A (sv) |
| AU (1) | AU5252993A (sv) |
| BR (1) | BR9305161A (sv) |
| CA (1) | CA2112052A1 (sv) |
| CO (1) | CO4180513A1 (sv) |
| CZ (1) | CZ281393A3 (sv) |
| FI (1) | FI935780A (sv) |
| HU (1) | HUT69703A (sv) |
| IL (1) | IL108098A0 (sv) |
| MX (1) | MX9308025A (sv) |
| NO (1) | NO934721L (sv) |
| PL (1) | PL301578A1 (sv) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| US5747540A (en) * | 1996-10-21 | 1998-05-05 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| US7119085B2 (en) | 2000-03-23 | 2006-10-10 | Elan Pharmaceuticals, Inc. | Methods to treat alzheimer's disease |
| EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| MXPA03002788A (es) * | 2000-09-29 | 2004-12-13 | Neurogen Corp | Moduladores de receptor c5a de molecula pequena de alta afinidad. |
| DE60203623T2 (de) * | 2001-07-19 | 2006-01-19 | CV Therapeutics, Inc., Palo Alto | Substituierte piperazinderivate und ihre verwendung als fettsaüre-oxidationsinhibitoren |
| BR0213139A (pt) | 2001-10-04 | 2004-08-10 | Elan Pharm Inc | Composto, método de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto e composição farmacêutica |
| AU2003303141A1 (en) | 2002-04-30 | 2004-07-22 | Elan Pharmaceuticals, Inc. | Hydroxypropyl amides for the treatment of alzheimer's disease |
| JP4698991B2 (ja) * | 2004-09-14 | 2011-06-08 | 日本曹達株式会社 | ピリジルメチルカルバミン酸エステル化合物、その製造方法及びピリジルメチルアミン化合物の製造方法 |
| JP4721214B2 (ja) * | 2004-09-14 | 2011-07-13 | 日本曹達株式会社 | ピリジルメチルカルバミン酸エステル化合物及びピリジルメチルアミン化合物の製造方法 |
| KR20080015079A (ko) | 2005-04-08 | 2008-02-18 | 코멘티스, 인코포레이티드 | 베타 세크레타제 활성을 억제하는 화합물 및 이것의 사용방법 |
| US8791135B2 (en) * | 2008-07-01 | 2014-07-29 | Purdue Research Foundation | Nonpeptide HIV-1 protease inhibitors |
| CN110872251A (zh) * | 2019-11-28 | 2020-03-10 | 卡博金艾美斯医药(上海)有限公司 | N-乙基吡啶甲胺三氟乙酸盐及其晶体、制备工艺和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0361341A3 (en) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutics for aids based on inhibitors of hiv protease |
| WO1991008221A1 (en) * | 1989-12-04 | 1991-06-13 | Wisconsin Alumni Research Foundation | Peptide inhibitors of hiv protease |
| GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
-
1993
- 1993-12-15 MX MX9308025A patent/MX9308025A/es unknown
- 1993-12-17 CZ CZ932813A patent/CZ281393A3/cs unknown
- 1993-12-20 PL PL93301578A patent/PL301578A1/xx unknown
- 1993-12-20 HU HU9303677A patent/HUT69703A/hu unknown
- 1993-12-20 NO NO934721A patent/NO934721L/no unknown
- 1993-12-20 IL IL10809893A patent/IL108098A0/xx unknown
- 1993-12-20 AU AU52529/93A patent/AU5252993A/en not_active Abandoned
- 1993-12-20 CO CO93423578A patent/CO4180513A1/es unknown
- 1993-12-20 EP EP93310355A patent/EP0609625A1/en not_active Withdrawn
- 1993-12-21 CA CA002112052A patent/CA2112052A1/en not_active Abandoned
- 1993-12-21 CN CN93112960A patent/CN1092410A/zh active Pending
- 1993-12-21 JP JP5321876A patent/JPH06256277A/ja not_active Withdrawn
- 1993-12-21 FI FI935780A patent/FI935780A/sv not_active Application Discontinuation
- 1993-12-21 BR BR9305161A patent/BR9305161A/pt not_active Application Discontinuation
- 1993-12-22 KR KR1019930029120A patent/KR940014336A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR940014336A (ko) | 1994-07-18 |
| AU5252993A (en) | 1994-07-07 |
| CN1092410A (zh) | 1994-09-21 |
| JPH06256277A (ja) | 1994-09-13 |
| NO934721L (no) | 1994-06-23 |
| PL301578A1 (en) | 1994-06-27 |
| CO4180513A1 (es) | 1995-06-07 |
| BR9305161A (pt) | 1994-11-01 |
| CZ281393A3 (en) | 1994-07-13 |
| CA2112052A1 (en) | 1994-06-23 |
| EP0609625A1 (en) | 1994-08-10 |
| HUT69703A (en) | 1995-09-28 |
| HU9303677D0 (en) | 1994-04-28 |
| FI935780A0 (fi) | 1993-12-21 |
| IL108098A0 (en) | 1994-04-12 |
| MX9308025A (es) | 1994-08-31 |
| NO934721D0 (no) | 1993-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI955315A (sv) | Inhibitorer av HIV proteas, som användbara vid behandling av AIDS | |
| NO893400L (no) | Hiv protease inhibitorer egnet for behandling av aids. | |
| EP0604182A3 (en) | HIV protease inhibiting compounds. | |
| BR9407782A (pt) | Inibidores de protease do HIV | |
| EP0434365A3 (en) | Hiv protease inhibitors useful for the treatment of aids | |
| IL102428A0 (en) | Inhibitors of hiv protease useful for the treatment of aids | |
| FI935780A (sv) | HIV-proteasinhibitorer, vilka aer anvaendbara vid behandling av AIDS | |
| IL105973A0 (en) | Inhibitors of hiv protease useful for the treatment of aids | |
| ZA925023B (en) | Inhibitors of HIV protease useful for the treatment of AIDS | |
| GB9515802D0 (en) | Hiv protease inhibitors useful for the treatment of aids | |
| EP0912170A4 (en) | HIV PROTEASE INHIBITORS USEFUL IN AIDS TREATMENT | |
| EP0914125A4 (en) | HIV protease inhibitors, useful in AIDS treatment. | |
| ZA928563B (en) | HIV protease inhibitors useful for the treatment of AIDS. | |
| GB9613488D0 (en) | HIV protease inhibitors useful in the treatment of aids | |
| ZA939475B (en) | Inhibitors of HIV protease useful for the treatment of Aids | |
| ZA892627B (en) | Hiv protease inhibitors useful for the treatment of aids | |
| ZA896430B (en) | Hiv protease inhibitors useful for the treatment of aids | |
| ZA9010125B (en) | Hiv protease inhibitors useful for the treatment of aids | |
| GB9622443D0 (en) | HIV protease inhibitors useful for the treatment of aids | |
| GB9609663D0 (en) | HIV Protease inhibitors useful for the treatment of aids | |
| GB9613487D0 (en) | HIV protease inhibitors useful for the treatment of aids | |
| NO920023D0 (no) | Hiv-proteaseinhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |